Skip to main content

What condition is Revcovi used to treat?

Medically reviewed by Drugs.com. Last updated on Oct 28, 2024.

Official Answer by Drugs.com

Revcovi is used to treat adenosine deaminase severe combined immune deficiency, an inherited disorder where patients lack immune protection from bacteria, viruses, and fungi.

In October 2018, the U.S. Food and Drug Administration (FDA) granted approval to Revcovi (elapegademase-lvlr) injection from Leadiant Biosciences. Revcovi is an intramuscular (IM) enzyme replacement therapy for treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in children and adults.

See also:

Drug information

Related support groups